nifuroxazide Capsules 200 mg

This company develops and manufactures a range of healthcare products, focusing on allergies, autism spectrum disorder, chemotherapy-induced nausea and vomiting (CINV), and appetite loss. Their product portfolio includes solid oral forms, liquid oral forms, topical formulations, and disinfectants. Key dosage forms include sprays, lozenges, gels, and mouthwashes. They operate in regions such as the EU and North America, adhering to Good Manufacturing Practices (GMP) certifications. Their commitment to innovation is demonstrated through product patents and a continuous launch of new products like DILO® spray, MEDISTAN® lozenges, NAXIDERM® gel, SEPTA®, and SEPTIX® disinfectants.